Single Targeting of MET in EGFR-Mutated and MET-Amplified Non-Small Cell Lung Cancer

Researchers investigated the efficacy of a single MET inhibitor in EGFR-mutant, MET-amplified lung cancer cells and the matched clinical cases and patient-derived cells.